West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
218.87
-0.13 (-0.06%)
At close: Jun 27, 2025, 4:00 PM
219.00
+0.13 (0.06%)
After-hours: Jun 27, 2025, 7:43 PM EDT
WST Revenue
West Pharmaceutical Services had revenue of $698.00M in the quarter ending March 31, 2025, with 0.37% growth. This brings the company's revenue in the last twelve months to $2.90B, down -1.12% year-over-year. In the year 2024, West Pharmaceutical Services had annual revenue of $2.89B, down -1.92%.
Revenue (ttm)
$2.90B
Revenue Growth
-1.12%
P/S Ratio
5.48
Revenue / Employee
$273,189
Employees
10,600
Market Cap
15.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
WST News
- 3 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - GlobeNewsWire
- 9 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit – WST - GlobeNewsWire
- 15 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - GlobeNewsWire
- 19 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST - PRNewsWire
- 5 weeks ago - 69 May Aristocrats: Buy 1 Of 38 "Safer" Dividend Dogs - Seeking Alpha
- 7 weeks ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST) - GlobeNewsWire
- 2 months ago - Best Dividend Aristocrats For May 2025 - Seeking Alpha